Protagonist Therapeutics, Inc. (PTGX)
95.24
+2.99
(+3.24%)
USD |
NASDAQ |
Dec 12, 16:00
95.24
0.00 (0.00%)
After-Hours: 17:31
Protagonist Therapeutics Total Long Term Debt (Quarterly): 8.521M for Sept. 30, 2025
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Johnson & Johnson | 39.41B |
| ADMA Biologics, Inc. | 81.82M |
| Regeneron Pharmaceuticals, Inc. | 2.706B |
| Vanda Pharmaceuticals, Inc. | 8.598M |
| Bristol Myers Squibb Co. | 50.57B |